Search

Your search keyword '"Kiweewa, Flavia Matovu"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Kiweewa, Flavia Matovu" Remove constraint Author: "Kiweewa, Flavia Matovu"
40 results on '"Kiweewa, Flavia Matovu"'

Search Results

Catalog

Books, media, physical & digital resources

4. Comparison of Antiretroviral Therapies in Pregnant Women Living With Human Immunodeficiency Virus and Hepatitis B Virus

5. Brief Report: Impact of Antiretroviral Regimen on Pregnancy and Infant Outcomes in Women With HIV/ HBV Coinfection

6. Use of the dapivirine vaginal ring and effect on cervical cytology abnormalities.

9. Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study

10. Impact and experience of participant engagement activities in supporting dapivirine ring use among participants enrolled in the phase III MTN-020/ASPIRE study

12. Acquisition of Sexually Transmitted Infections among Women Using a Variety of Contraceptive Options: A prospective Study among High-risk African Women

15. 2079. Comparison of Recency Assays to Estimate HIV Incidence in the SIENA (eStimating hIv incidEnce amoNg Agyw) Study in Uganda

17. Community Health Workers Improve HIV Disclosure Among HIV-Affected Sexual Partners in Rural Uganda: A Quasi-Experimental Study

18. Brief Report: Dapivirine Vaginal Ring Use Does Not Diminish the Effectiveness of Hormonal Contraception

19. Intramuscular depot medroxyprogesterone acetate accentuates bone loss associated with tenofovir disoproxil fumarate-containing antiretroviral therapy initiation in young women living with HIV (the BONE: CARE study): a prospective cohort study in Uganda

20. Community health workers improve HIV disclosure among HIV-affected sexual partners in rural Uganda : a quasi-experimental study

22. The impact of participant engagement activities in supporting dapivirine ring use among participants enrolled in the Phase III MTN-020/ASPIRE study

23. Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study

25. Correlates of Adherence to the Dapivirine Vaginal Ring for HIV-1 Prevention.

27. Anti-Retroviral–Based Hiv Pre-Exposure Prophylaxis For Women : Recent Advances and Next Steps

29. Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women

30. Characteristics of Women Enrolled into a Randomized Clinical Trial of Dapivirine Vaginal Ring for HIV-1 Prevention

33. Baseline Characteristics of HIV-1 Negative Women Enrolled into a Clinical Trial of Dapivirine Vaginal Ring for HIV-1 Prevention

34. Prevalent and Incident Gonorrhea and Chlamydia Infections among Oral Contraceptive and Depot Medroxyprogesterone Acetate Users in MTN-003 (VOICE)

35. Hematologic and Chemistry Normal Laboratory Values among Healthy Ugandan Women Screened for a Pre-exposure Prophylaxis Trial: The MTN-003(VOICE) Study

37. Baseline Characteristics of HIV-1 Negative Women Enrolled into a Clinical Trial of Dapivirine Vaginal Ring for HIV-1 Prevention.

38. Low knowledge levels and high willingness to use oral Pre-Exposure Prophylaxis (PrEP) among Key Populations in Kampala, Uganda: Implications for targeted educational interventions.

39. Brief Report: Impact of Antiretroviral Regimen on Pregnancy and Infant Outcomes in Women With HIV/ HBV Coinfection.

40. Brief Report: Dapivirine Vaginal Ring Use Does Not Diminish the Effectiveness of Hormonal Contraception.